Imagion Biosystems Limited
IBXXF
$0.015
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.23% | -97.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.23% | -97.59% | |||
| Cost of Revenue | 2.14% | 763.96% | |||
| Gross Profit | -2.12% | -158.65% | |||
| SG&A Expenses | 2.10% | -30.61% | |||
| Depreciation & Amortization | 0.00% | -44.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.11% | 32.56% | |||
| Operating Income | -2.13% | -733.68% | |||
| Income Before Tax | -2.13% | -196.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.13% | -196.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.13% | -196.08% | |||
| EBIT | -2.13% | -733.68% | |||
| EBITDA | -2.11% | -655.25% | |||
| EPS Basic | 0.00% | 16.13% | |||
| Normalized Basic EPS | -6.25% | 15.79% | |||
| EPS Diluted | -3.85% | 16.13% | |||
| Normalized Diluted EPS | -6.25% | 15.79% | |||
| Average Basic Shares Outstanding | 0.00% | 251.56% | |||
| Average Diluted Shares Outstanding | 0.00% | 251.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||